Profile data is unavailable for this security.
About the company
OSE Immunotherapeutics SA, formerly Orphan Synergy Europe Pharma SA, is a France-based company, engaged in clinical stage biotechnological sector. It develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The Company's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. It provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
- Revenue in EUR (TTM)2.23m
- Net income in EUR-23.00m
- Incorporated2004
- Employees62.00
- LocationOSE Immunotherapeutics SA22, boulevard Benoni GoullinNANTES 44200FranceFRA
- Phone+33 228291010
- Fax+33 141219107
- Websitehttps://ose-immuno.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AB Science SA | 970.00k | -11.99m | 101.55m | 53.00 | -- | -- | -- | 104.69 | -0.2492 | -0.2492 | 0.0195 | -0.4111 | 0.0393 | 0.9672 | 4.89 | 18,301.89 | -48.58 | -65.95 | -316.31 | -515.17 | 60.52 | 88.41 | -1,235.57 | -1,148.98 | 1.02 | -12.17 | -- | -- | 1.25 | -10.63 | 11.97 | -- | -6.55 | -- |
| Eurofins-Cerep SA | 46.17m | 9.21m | 109.96m | 233.00 | 11.94 | 1.83 | 9.82 | 2.38 | 1,826.41 | 1,826.41 | 9,160.00 | 11,939.29 | 0.6814 | 1.66 | 6.04 | 220,892.00 | 13.60 | 15.19 | 16.06 | 18.94 | 85.57 | 67.30 | 19.95 | 19.72 | 5.17 | 112.42 | 0.00005 | 0.00 | 14.45 | 14.30 | 17.09 | 24.52 | -- | -- |
| DBV Technologies SA | 14.51m | -67.07m | 110.04m | 104.00 | -- | 0.8481 | -- | 7.58 | -0.7069 | -0.7069 | 0.1525 | 1.35 | 0.0732 | -- | 1.18 | 139,498.30 | -33.86 | -53.18 | -40.10 | -65.47 | -- | 93.62 | -462.30 | -1,145.92 | -- | -- | 0.0388 | -- | 224.69 | -1.71 | 24.27 | -- | -34.47 | -- |
| Maat Pharma SA | 2.23m | -19.72m | 111.18m | 50.00 | -- | 4.54 | -- | 49.90 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Transgene SA | 7.63m | -22.33m | 125.73m | 158.00 | -- | 7.99 | -- | 16.47 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Adocia SA | 2.15m | -21.16m | 129.59m | 78.00 | -- | -- | -- | 60.27 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Eurobio Scientific SA | 130.00m | 4.84m | 149.63m | 137.00 | 33.84 | 0.9112 | 8.32 | 1.15 | 0.4315 | 0.4315 | 11.59 | 16.02 | 0.4018 | 3.19 | 4.31 | 948,927.00 | 1.49 | 16.91 | 1.80 | 21.53 | 47.11 | 50.95 | 3.72 | 23.34 | 2.32 | 4.03 | 0.3666 | 0.00 | -14.81 | 20.80 | -80.61 | -- | 20.02 | -- |
| Cellectis SA | 11.19m | -72.34m | 172.92m | 235.00 | -- | 2.07 | -- | 15.45 | -1.22 | -1.03 | 0.1642 | 1.16 | 0.04 | -- | 1.41 | 47,620.42 | -27.82 | -24.08 | -42.40 | -30.69 | -- | -64.64 | -694.72 | -308.24 | -- | -- | 0.552 | -- | -64.26 | -15.57 | -20.55 | -- | -26.15 | -- |
| Inventiva SA | 17.48m | -110.43m | 173.44m | 112.00 | -- | -- | -- | 9.92 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Aelis Farma SA | 9.05m | -5.08m | 175.00m | 26.00 | -- | 13.26 | -- | 19.33 | -0.3907 | -0.3907 | 0.7019 | 0.9957 | 0.2765 | -- | 2.41 | 348,230.80 | -15.51 | -24.53 | -25.59 | -40.55 | -- | -- | -56.09 | -109.62 | 2.47 | -- | 0.1547 | -- | 137.70 | -- | 64.46 | -- | 37.35 | -- |
| Ose Immunotherapeutics SA | 2.23m | -23.00m | 179.37m | 62.00 | -- | 7.74 | -- | 80.54 | -1.18 | -1.18 | 0.1166 | 1.06 | 0.0256 | -- | 3.22 | -- | -26.46 | -17.17 | -33.15 | -20.55 | -- | -- | -1,032.87 | -94.71 | -- | -97.81 | 0.6659 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Innate Pharma SA | 51.90m | -7.57m | 204.58m | 179.00 | -- | 3.94 | -- | 3.94 | -0.0939 | -0.0939 | 0.6451 | 0.642 | 0.2648 | -- | 5.67 | 289,949.70 | -3.86 | -8.83 | -4.87 | -12.11 | 94.50 | 93.17 | -14.59 | -55.55 | -- | -- | 0.6408 | -- | 4.68 | -8.27 | 86.94 | -- | 10.50 | -- |
| Sensorion SA | 0.00 | -22.06m | 231.79m | 50.00 | -- | 4.34 | -- | -- | -0.2063 | -0.2063 | 0.00 | 0.1779 | 0.00 | -- | -- | -- | -51.64 | -35.12 | -71.66 | -46.97 | -- | -- | -- | -- | -- | -- | 0.0794 | -- | -- | -- | 4.94 | -- | 126.45 | -- |
| Genfit SA | 38.18m | -28.89m | 235.35m | 159.00 | -- | 3.46 | -- | 6.16 | -0.5814 | -0.5814 | 0.7681 | 1.36 | 0.1961 | 542.00 | 3.52 | 240,100.60 | -14.84 | -12.57 | -18.55 | -15.30 | 94.32 | 94.96 | -75.69 | -76.23 | 2.94 | -7.78 | 0.5080 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
Data as of May 31 2024. Currency figures normalised to OSE Immunotherapeutics SA's reporting currency: Euro EUR
2.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Mandarine Gestion SAas of 29 Feb 2024 | 230.00k | 1.06% |
| Saint Olive Gestion SNCas of 29 Dec 2023 | 120.00k | 0.55% |
| La Fran�aise Asset Management SASas of 31 Jan 2024 | 110.00k | 0.51% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 30.48k | 0.14% |
| Alphajet Fair Investors SASas of 28 May 2024 | 13.00k | 0.06% |
| Chaussier Gestion SAas of 28 Mar 2024 | 12.00k | 0.06% |
| Gestys SAas of 26 Jan 2024 | 3.00k | 0.01% |
| CATAM Asset Management AGas of 30 Apr 2024 | 0.00 | 0.00% |
More ▼
Data from 23 Feb 2024 - 28 May 2024Source: FactSet Research Systems Inc.
